Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Everolimus, Cisplatin, and Paclitaxel in Metastatic Breast Cancer
NCT01031446Phase 2Completed
- Sponsor
- Vanderbilt-Ingram Cancer Center
- Start
- Oct 2009
- Primary completion
- Dec 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of everolimus in breast cancer, sponsored by Vanderbilt-Ingram Cancer Center. Started Oct 2009; status: completed.
02
Drugs
everolimus
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT01031446.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01031446.